Sanofi Ends Development of Two Phase III Drugs

Article

-

Sanofi has discontinueddevelopment of two investigational drugs in Phase III development, iniparib, a drug to treat non-small cell lung cancer, and otamixaban, an anticoagulant, based on recent clinical results. Sanofi will take an after-tax change of $285 million for iniparib.

Recent Videos
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content
Women's Day poster with woman silhouette and fists inside in paper cut and copy space, 3D illustration. Girl face poster for feminism, independence, freedom, empowerment, activism for women rights | Image Credit: © AdriaVidal – stock.adobe.com

International Women’s Day 2025: Celebrating Women in Science

Felicity Thomas
March 8th 2025
Article

Supporting the prosperity of women in science fields benefits the bio/pharmaceutical industry.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
November 14th 2023
Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Adragos Pharma Completes Liquid Filling Line Installation in Germany

Patrick Lavery
March 7th 2025
Article

The €4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Emerson Releases Fixed Point Gas Detector Cutting Down on False Alarms

Patrick Lavery
March 7th 2025
Article

The detector features specialized, solid-state dual infrared (IR) sources and dual IR receivers which provide continual cross-checks and internal adjustments to adhere to factory calibration.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Makes Class-Wide Labeling Changes to Testosterone Products

Patrick Lavery
March 6th 2025
Article

The alterations are the result of an agency review of findings from a clinical trial, and data from required postmarket studies.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Ross Announces PFA-Coated Ribbon Blender to Be Offered for Sensitive Applications

Patrick Lavery
March 6th 2025
Article

The company said this blender supports applications for which either stainless steel or carbon steel may not be suitable.